Literature DB >> 26900622

Mechanistic Insight into Receptor-Mediated Delivery of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantamethamidyl Host:Guest pDNA Nanoparticles to CD44(+) Cells.

Vivek Badwaik1, Linjia Liu1, Dinara Gunasekera1, Aditya Kulkarni1, David H Thompson1.   

Abstract

Targeted delivery is a key element for improving the efficiency and safety of nonviral vectors for gene therapy. We have recently developed a n>an class="Gene">CD44 receptor targeted, hyaluronic acid-adamantamethamidyl based pendant polymer system (HA-Ad), capable of forming complexes with cationic β-cyclodextrins (CD-PEI(+)) and pDNA. Complexes formed using these compounds (HA-Ad:CD-PEI(+):pDNA) display high water solubility, good transfection efficiency, and low cytotoxicity. Spatial and dynamic tracking of the transfection complexes by confocal microscopy and multicolor flow cytometry techniques was used to evaluate the target specificity, subcellular localization, and endosomal escape process. Our data shows that cells expressing the CD44 receptor undergo enhanced cellular uptake and transfection efficiency with HA-Ad:CD-PEI(+):pDNA complexes. This transfection system, comprised noncovalent assembly of cyclodextrin:adamantamethamidyl-modified hyaluronic acid via host:guest interactions to condense pDNA, is a potentially useful tool for targeted delivery of nucleic acid therapeutics.

Entities:  

Keywords:  CD44 receptor; cationic β-cyclodextrin; hyaluronic acid conjugate; pDNA transfection

Mesh:

Substances:

Year:  2016        PMID: 26900622      PMCID: PMC5318300          DOI: 10.1021/acs.molpharmaceut.6b00078

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  34 in total

Review 1.  Targeted gene delivery to the lung.

Authors:  Manish K Aneja; Johannes-Peter Geiger; Anne Himmel; Carsten Rudolph
Journal:  Expert Opin Drug Deliv       Date:  2009-06       Impact factor: 6.648

Review 2.  Non-viral nucleic acid delivery: key challenges and future directions.

Authors:  Mahmoud Elsabahy; Adil Nazarali; Marianna Foldvari
Journal:  Curr Drug Deliv       Date:  2011-05       Impact factor: 2.565

3.  Endocytosis of hyaluronidase-1 by the liver.

Authors:  Marie-Christine Gasingirwa; Jacqueline Thirion; Jeannine Mertens-Strijthagen; Simone Wattiaux-De Coninck; Bruno Flamion; Robert Wattiaux; Michel Jadot
Journal:  Biochem J       Date:  2010-09-01       Impact factor: 3.857

4.  Mechanistic studies of sequential injection of cationic liposome and plasmid DNA.

Authors:  Jing-Shi Zhang; Feng Liu; Christine C Conwell; Yadi Tan; Leaf Huang
Journal:  Mol Ther       Date:  2005-10-20       Impact factor: 11.454

5.  Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate.

Authors:  Min Sang Lee; Jung Eun Lee; Eunkyoung Byun; Nak Won Kim; Kyuri Lee; Haeshin Lee; Sang Jun Sim; Doo Sung Lee; Ji Hoon Jeong
Journal:  J Control Release       Date:  2014-07-01       Impact factor: 9.776

6.  Targeted drug and gene delivery systems for lung cancer therapy.

Authors:  Sneha Sundaram; Ruchit Trivedi; Chandrasekar Durairaj; Rajagopal Ramesh; Balamurali K Ambati; Uday B Kompella
Journal:  Clin Cancer Res       Date:  2009-11-17       Impact factor: 12.531

Review 7.  Immunology of neurological gene therapy: how T cells modulate viral vector-mediated therapeutic transgene expression through immunological synapses.

Authors:  Pedro R Lowenstein; Kurt Kroeger; Maria G Castro
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

Review 8.  CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation.

Authors:  M Zöller
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

9.  Microfluidic Assembly of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantane Host:Guest pDNA Nanoparticles.

Authors:  Aditya Kulkarni; Ross Verheul; Kyle Defrees; Christopher J Collins; Ryan A Schuldt; Alexander Vlahu; David H Thompson
Journal:  Biomater Sci       Date:  2013-10-01       Impact factor: 6.843

10.  Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells.

Authors:  J L Jainchill; S A Aaronson; G J Todaro
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

View more
  3 in total

1.  Tumor microenvironment dual-responsive core-shell nanoparticles with hyaluronic acid-shield for efficient co-delivery of doxorubicin and plasmid DNA.

Authors:  Tianqi Wang; Xiaoyue Yu; Leiqiang Han; Tingxian Liu; Yongjun Liu; Na Zhang
Journal:  Int J Nanomedicine       Date:  2017-07-04

2.  A New Hyaluronan Modified with β-Cyclodextrin on Hydroxymethyl Groups Forms a Dynamic Supramolecular Network.

Authors:  Jelica Kovačević; Zdeňka Prucková; Tomáš Pospíšil; Věra Kašpárková; Michal Rouchal; Robert Vícha
Journal:  Molecules       Date:  2019-10-25       Impact factor: 4.411

Review 3.  Hyaluronic Acid within Self-Assembling Nanoparticles: Endless Possibilities for Targeted Cancer Therapy.

Authors:  Manuela Curcio; Orazio Vittorio; Jessica Lilian Bell; Francesca Iemma; Fiore Pasquale Nicoletta; Giuseppe Cirillo
Journal:  Nanomaterials (Basel)       Date:  2022-08-18       Impact factor: 5.719

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.